Inappropriate inhaled corticosteroid prescribing in chronic obstructive pulmonary disease patients

Amelia Harrison, Brigitte Borg, Bruce Thompson, Mark Hew, Eli Dabscheck

Research output: Contribution to journalArticleResearchpeer-review

7 Citations (Scopus)

Abstract

The Australian National Chronic Obstructive Pulmonary Disease (COPD) guidelines recommend that inhaled corticosteroids (ICS) be reserved for patients with a post-bronchodilator forced expiratory volume in 1 s (FEV1) less than 50% predicted and those who experience ≥2 exacerbations in 12 months. In total, 707 COPD patients were identified from the lung function test database at our tertiary hospital; 52.4% of patients with a post-bronchodilator FEV1 ≥50% were prescribed an ICS. Significant discordance exists between guideline recommendations and inhaler prescription.

Original languageEnglish
Pages (from-to)1310-1313
Number of pages4
JournalInternal Medicine Journal
Volume47
Issue number11
DOIs
Publication statusPublished - Nov 2017

Keywords

  • COPD
  • guidelines
  • inhaled corticosteroids
  • over prescription

Cite this